Comparison of long-term efficacy and safety of infliximab and ustekinumab in the treatment of moderate-to-severe Crohn<i>'</i>s disease

LIN Ping, WANG Wei, YANG Yong, LIU Ping

Tianjin Medical Journal . 2026, (2): 206 -210 . DOI: 10.11958/20251483